Answers are grounded in this paper and cite their sources.
Reducing hyperglycemia through effective diabetes management in patients with type 1 or type 2 diabetes can reduce progression or development of diabetic complications: this article examines the need for effective pharmacological therapy while minimizing the risk of weight gain, and the role of advanced practice nurses (APNs) in helping patients with these issues. Insulin therapy is effective, but its potential side effects, including excessive weight gain, can undermine treatment success through adverse physiological consequences and patient demotivation. Educational and practical steps can be taken and therapy choices made that can limit this problem. APNs, working closely with patients who have diabetes, with diabetes nurse educators and with dietitians, have a role to play in weight management. Education concerning medical nutritional therapy and physical activity contributes to the overall care of the patient and effective self-management of diabetes. APNs need to maintain an awareness of insulin options and of other emerging diabetes therapies. Work performed at: Henry Ford Medical Center New Center One Division of Endocrinology, Diabetes, Bone and Mineral Disorders Detroit, MI Funding: The publication of this article has been supported by Novo Nordisk Inc. THE NEED FOR EFFECTIVE PHARMACOLOGICAL THERAPY IN PATIENTS WITH DIABETES Optimal glycemic control is paramount in the treatment of diabetes. Well-known, large-scale studies such as the Diabetes Control and Complications Trial (DCCT) in patients with type 1 diabetes and the United Kingdom Prospective Diabetes Study (UKPDS) or the Kumamoto study in patients with type 2 diabetes have conclusively shown that elevated levels of blood glucose are associated with the occurrence of microvascular complications, such as retinopathy and neuropathy (1, 2, 3). The DCCT was a prospective trial involving 1441 patients with type 1 diabetes randomized to either an intensive (three to four insulin injections/day or insulin pump) or conventional (one to two insulin injections/day) treatment protocol. Those in the intensive group achieved a better level of glycemic control than those in the conventional group (median HbA1c 7.3% vs. 9.1%, respectively; p < 0.001), and this was associated with a reduction of development or progression of microvascular complications of up to 76% (1). In the Kumamoto trial (2) involving 110 patients with type 2 diabetes, a better level of metabolic control was achieved with intensified insulin treatment (three or more insulin injections: rapid-acting insulin at mealtimes and intermediate-acting insulin at bedtime) compared with conventional treatment (two intermediate-acting insulin injections daily), with respective mean HbA1c values of 7.1% and 9.4% (p < 0.001). This improved control was associated with a reduction in risk for retinopathy of up to 76% over 6
No takes yet. Share an insight, caveat, or question.
A 2007 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: